Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

ENTYVIO treat-to-target strategy reduces ulcerative colitis complication risk in Phase IV VERDICT trial


Takeda launches ORZEYFUL in Japan and China for narcolepsy type 1


TAK-881 matches HYQVIA exposure while reducing infusion volume in Phase II/III PID study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Handling mutagenic extractable and leachable compounds released from devices

Presented by Ron Brown, Toxicologist at Risk Science Consortium and Piet Christieans, PhD, Scientific Director at Nelson Labs
10th February 2022


A Hybrid Approach to Continuous Biomanufacturing of Biosimilars

Presented by Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech
19th January 2023


The exogenously driven disruption of Bioprocessing

Presented by Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Pranjul Mishra, team lead of application science at Yokogawa Insilico Biotechnology
15th September 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia